Aplenzin
Product Images NDC 16590-922

2 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Aplenzin (NDC 16590-922). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Aplenzin Er 348mg Label 922)

Label Image (Aplenzin Er 348mg Label 922)
Packaging label of APLENZIN ER 348 mg extended-release tablets, containing 30 tablets, labeled by STAT RX USA LLC. The label states the product is a generic for bupropion hydrobromide extended-release, with manufacturer Sanofi-Aventis U.S. LLC. The label includes an alcohol interaction warning and a caution to keep out of reach of children.*
FDA Label Image

Chemical Structure (Aplenzin 01)

Chemical Structure (Aplenzin 01)
Chemical structure of the active ingredient in APLENZIN ER, showing a chlorophenyl ring with attached functional groups including a bromide salt (HBr).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.